In the U937 histiocytic cell line, we investigated the effect of calcium-mobilizing agents with or without tumor necrosis factor-a (TNF) on the regulation of the synthesis of plasminogen activator inhibitor-type 1 (PAI-l). Cultured U937 cells were stimulated with ionophore A23187 and thapsigargin with or without TNF. The response was analyzed in terms of cytosolic calcium mobilization, PAL1 accumulation in the medium, and PAI-1 mRNA expression. The study was extended to urokinase (uPA) secretion and surface expression of its receptor (uPAR). Using Fluo-3 as a calcium-indicator dye to measure cytosolic calcium mobilization, we showed by flow cytometry that both agents mobilized calcium in a dose-dependent manner. TNF provoked a slight calcium mobilization that was also observed by digital imaging microscopy. Association of TNF with the calcium-mobilizing agents potentiated the calcium mobilization. Both calciummobilizing agents induced at 18 hours a dose-dependent accumulation of PAL1 in culture medium, whereas uPA was not affected. TNF alone induced a more marked accumulation of PAI-1 than of uPA. Association of TNF with the agents induced a PAL1 response that was more than additive of YPE 1 PLASMINOGEN activator inhibitor (PAI-1) is a serine protease inhibitor that rapidly inhibits the tissuetype plasminogen activator, thereby preventing activation of plasminogen into plasmin.' This may result in a slowing down of fibrin degradation, both in the vasculature and at its surface. This is of prime interest, because a higher plasma level of PAI-1 is observed in patients with coronary heart diseases (CHD) and those presenting with insulin resistance, a syndrome that is associated with an increased risk of CHD.' As demonstrated by several independent groups, PAI-1 is released by activated platelets and produced in vitro by cultured vascular cells such as endothelial and smooth muscle cells.3 In vivo, a significant increase in the expression of PAI-1 mRNA has been observed by in situ hybridization techniques in human atherosclerotic By inhibiting the urokinase-type plasminogen activator (uPA) bound to its receptor (uPAR), PAL1 is also believed to be involved in the control of extracellular matrix degradation, which is a critical step for tissue remodeling, cell migration, and tumor inva~ion."~~ Interestingly, uPAR expression is augmented in 
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macrophages and smooth muscle cells of human atherosclerotic vessels." Thus, it now becomes evident that an increase in PAI-1 not only may be related to the control of fibrin degradation at the luminal site of the endothelium or in the intima but also may affect local matrix proteolysis, thus controlling the migration of proliferating vascular cells and angiogenesis" or migratiodrecruitment of monocytes/macrophages. '"14 Many of the pathophysiologic factors that are released or are present in the atherosclerotic vessels were demonstrated in vitro to significantly modify PAI-1 expression of cultured vascular cells. These include atherogenic cytokines such as tumor necrosis factor-a (TNF), and interleukin (IL)-l,I9-" and growth factor^.'^.^^ Calcium is believed to play a key role in numerous intracellular function~,'~.'~ some of which (eg, cell proliferation, apoptosis, angiogenesis, etc) are involved in the development of atherothrombosis.
Some of the pathogenic factors mentioned above that augment PAI-1 synthesis were independently demonstrated also to alter by different ways the fine tuning of cytosolic calcium concentration. This is the case with oxidized low-density lipoproteins (LDL)26 and various agonists that bind to tyrosine kinase-linked receptors, such as growth factors or Gprotein-linked receptors such as thrombin.27 However, the role of calcium in the cytokine effect is not clear, and that of tumor necrosis factor-a (TNF) is still a matter of deIn atherosclerotic vessels, an important feature of vascular cells is that they are exposed to many signals, and a cross-talk between the resulting intracellular signalling pathways may occur. For example, TNF30,31 and calcium i n f l u~~' .~~ both activate the mitogen-activated protein (MAP) kinase pathway. TNF potentiates calcium signals induced by b r a d~k i n i n ,~~ and the calcium ionophore ionomycin synergizes the phorbol ester-induced expression of uPA in a renal For personal use only. on October 3, 2017. by guest www.bloodjournal.org From cell line.3' However, the role of calcium itself or in interaction with other agonists on PAI-1 synthesis has not been investigated.
Enhanced expression of PAI-1 mRNA was detected in macrophages present in the atherosclerotic vessels' and those surrounding the lesion in an experimental model of thrombosis in the rabbit. 36 Moreover, it has been demonstrated in vitro that peripheral blood monocyte^^'^^^ and macrophages isolated from human atheromatous plaque3' both secrete PAI-1. Because the human lymphoma-derived histiocytic line U937 was shown to synthesize and secrete significant amounts of PAL2 and PAI-1,'2.40 this cell line represents an interesting model to study the regulation of PM-1 synthesis in the context of the role played by monocytedmacrophages in the development of atherothrombosis. Therefore, we investigated in U937 cells the effect of calcium-mobilizing agents on PAI-1 and uPA synthesis and uPAR membrane expression. The molecules studied were ionophore A23 187 and thapsigargin (TG), both of which increase cytosolic calcium in different ways. The former is well known to increase membrane permeability to calcium and also to discharge calcium from internal stores. The second irreversibly inhibits the endoplasmic CaZ+-ATPase pump that drives the ion back into the internal stores, thus creating a drastic desequilibrium in favor of a permanent leak of calcium in the cytosolic compartment:' The effects of ionophore A23187 and TG were also studied in association with TNF.
Results showed that the agent-induced increase in cytosolic calcium upregulates PAL1 mRNA expression, leading to a drastic increase in PAL1 accumulation in culture medium. TNF alone stimulated PAL1 synthesis. Association of TNF and calcium-mobilizing agents potentiated the PAI-1 synthesis, indicating that in U937 cells, calcium positively regulates the TNF-induced increase in PAI-1 synthesis, while uPA and uPAR behaved differently.
MATERIALS AND METHODS
Chemicals. Fetal calf serum (FCS) and cell culture reagents were purchased from Eurobio (Les Ullis, France). A23187, TG, and dimethyl sulfoxide (Me,SO) were purchased from Sigma Chemicals CO (La Verpillibre, France). Human recombinant TNF-a (specific activity, 3.8 X lo7 U/mg) was from Euromedex (Souffelweyersheim, France), and human recombinant L-l@ (5 X lo7 Wmg) was from Boehringer Mannheim (Meylan, France). Fluo-3-acetoxymethyl ester (Nuo3-AM) and 5,5'-dimethyl BAPTA-AM were from Molecular Probes (Eugene, Oregon). Nylon positively charged membranes and agarose were from Appligene (Illkirch, France). Monoclonal antibodies specific for PAI-I and cDNA human probes for PAI-l were a gift from Prof D. Collen, Prof P.J. Declerck, and Dr L. Nelles Cell culture. The U937 histiocytic cell line (provided by Dr A.M. Benoliel, Marseille, France) was maintained in suspension in Ham's F12Eagle.s minimal essential medium (MEM; 1/1 vol/vol) supplemented with 10% heat inactivated FCS, 2 mmovL L-glutamine, 100 U/mL penicillin, and 100 pg/mL streptomycin, under 5% COz in a humidified atmosphere at 37°C. All the experiments, except video imaging, were performed at a cell density ranging between 1 X 106/mL and 2 X 106/mL.
Assays. Cell viability was assessed by the quantification of lactate dehydrogenase (LDH) release in culture medium. To this end, the cell suspension was immediately centrifuged at 2,OOOg for 20 minutes at 4°C to sediment cells and cellular debris. Supernatants collected at 4°C were immediately assayed for the LDH assay using a routine clinical assay performed on an automatic analyzer (Hitachi 717, Boehringer Mannheim, Mannheim, Germany). Results were expressed in international units (IU) per IO6 cells. The rest of the supernatant was stored at -20°C. pending measurements of PAI-l and uPA accumulation in culture medium. PAL1 and uPA antigen assays were performed using an enzyme-linked immunosorbent assay (ELISA) as described by Declerck et al?2, 43 Results were expressed in nanograms of PAI-l or uPA antigen (PAI-1 Ag or uPA Ag) per lo6 cells.
Measurement of inositol phosphate production. U937 cells (2 X 106/mL) were. first incubated overnight in an inositol-poor medium (M199) containing my~-[~H]inositol (4 pCi/mL). Cells were washed twice and then incubated for 15 minutes with LiCl (40 mmolfl). They were stimulated either with TNF (100 U/mL) or IL-l (10 U/ mL) for various times, and the stimulation was stopped by addition of 10 mmolfl ice-cold formic acid. Inositol phosphates were then extracted and separated on Dowex anion exchange chromatography, as described by Vigne et al."
Cell stimulation. In the experiments using calcium-mobilizing agents, cells in 1% FCS-containing medium were stimulated with the agent (A23187 in pure ethanol and TG in pure MezSO) added as a single dose at the indicated final concentration and left for 30 minutes. Proper controls with an equivalent volume of ethanol or MqSO alone were proven not to affect the responses studied. The stimulated cell suspension was then centrifuged for 5 minutes at 300g, 22"C, and the supernatant was carefully eliminated to remove the agents. The cellular pellet was resuspended in the 1% FCS medium, and the length of incubation from the addition of the agent depended on the type of analysis performed: 18 hours for PAI-l Ag and LDH assays in the medium, and 1,3,5, and 18 hours for mRNA expression. In the studies involving association of agents and TNF, the cytokine was added as a single dose (final concentration of 100 U/mL) 2 hours before the agent. After the washing procedure, TNF was added again at the same concentration in the 1% FCS-containing medium, and incubation continued for indicated times as described above. The same procedure applied for TNF alone. In the experiments designed to study the effect of calcium-free medium, the 1% FCS-containing medium was supplemented with EGTA to completely chelate the calcium without any excess of EGTA (calciumfree medium). The measurement of calcium concentration in the culture medium using a routine clinical assay (Hitachi 717) confirmed that all the calcium was chelated. The cells were incubated in this medium for 2 hours, then were stimulated with calciummobilizing agents for 30 minutes, and were resuspended in the calcium-free medium. From the onset of stimulation, incubation lasted 3 hours for mRNA analysis and 18 hours for LDH and PAI-I Ag assays. In experiments using cycloheximide, the inhibitor was added at a final concentration of 15 pmol/L at 30 minutes before and until the end of the agent stimulation. Then, cycloheximide was continued at 3 pmoYL for the next 2.5 hours (&A expression) or 17.5 hours (PAL1 Ag secretion). This protocol was selected on the basis of a minimal cytotoxic effect under our experimental conditions of stimulation.
Measurement of intracellular calcium mobilization byflow cytometry andfluorescence digital imaging. Intracellular calcium mobilization was measured by flow cytometry using the fluorescent probe
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Fluo3-AM, which has been shown to be a reliable dye to detect changes in cytosolic calcium." Fluo3-AM was dispersed in Me,SO containing 20% pluronic acid. In all the experiments, cells in 1% FCS medium were incubated with 1 pmoVL Ftuo3-AM for 30 minutes, and experiments on dye-loaded cells were performed within the next 30 to 45 minutes. Indeed, we observed a substantial decay in basal fluorescence at 1 hour after the end of loading the cells, which seemed to perturb the fluorescence response in cells stimulated with the calcium-mobilizing agents. This was not related to a dyeinduced cell membrane disruption, as cell viability measured by flow cytometry after iodine propidium treatment revealed that at least 95% of the cells were viable at the time of the measurement. This is perhaps the consequence of a spontaneous leakage of the probe out of the cell or of an intracellular metabolization into an inactive probe. In the experiments with a calcium-free medium, cells were first incubated in this medium for 2 hours, loaded with Flu03-M as above, and then stimulated with the agents before the fluorescence was read. To assess the time-dependent persistence of the intracellular calcium-mobilizing effect of the agents after they have been eliminated, U937 cells in 1% FCS-containing medium were stimulated for 30 minutes, the agents were removed, and the cells were resuspended in 1% FCS-containing medium. The dye was subsequently loaded at different times after the washing procedure, and fluorescence was directly read. Analyses were performed on an EPICS-Profile I1 cytofluorograph (Coulter Electronics Inc. Hialeah, K) equipped with an air-cooled, 488-nm argon-ion laser that was run at 15 mW of power. The linearity of the linear amplifier was performed using four different quantum-24 beads having 4,240, 17,000,38,000, and 77,900 fluorescein equivalents (Flow Cytometry Standards Corporation, Research Triangle Park, NC) per bead. For each measurement, 10, OOO events were collected and analyzed at typical rates of 400 to 600 cells per second. Cells were gated from debris and putative cell clumps on the basis of forward versus right angle scatter. Cells excited at 488 nm were detected at 525 nm. The green fluorescence, which represents the specific binding of cytosolic calcium, was measured on fluorescence channel 1 (FL 1) and collected after a 525-nm band pass filter. The data were collected in monoparameter histograms (256 channels) displaying relative log fluorescence intensity versus cell number by calculating the median channel number. Data acquisition on the flow cytometer was performed with the EPICS Profile software (Coulter Electronics). Normalized fluorescence is expressed as the ratio of mean fluorescence over mean basal fluorescence. Fluorescence digital imaging microscopy was also used to analyze calcium mobilization at the singlecell level in cells stimulated with either TNF (100 UlmL) or IL-l (10 U/mL). This was performed according to the protocol described by Kaplanski et Briefly, cells (500,000/mL) were loaded with Fluo3-AM as described above and examined with an Olympus IMT2 inverted microscope (Olympus, Tokyo, Japan) equipped with a Reichert heating stage (Reichert, Vienna, Austria). Fluorescence measurements were performed with a Lhesa 4036 SIT video camera (Lhesa, Cergy Pontoise, France) mounted on the microscope and connected to a PC vision + digitizer (Imaging Technology, Wobum, MA) set in an IBM-compatible desk computer. Changes in fluorescence were recorded every 6 seconds for a period of time up to IO minutes. Normalized fluorescence in a single responsive cell is expressed as the ratio of fluorescence over the basal fluorescence.
Flow cyrometry analysis of uPAR expression. Quantitative expression of uPAR on U937 cells under the various conditions of stimulation was performed by flow cytofluometry, as described."
Briefly, IO6 cells were sedimented and treated for 2 minutes with 0.5 mL of 50 mmol/L glycine-HC1 pH 3.0, 100 mmol/L NaCl; then neutralized by addition of 0.5 mL 50 mmoVL HEPES pH 7.5, 100 mmoVL NaCl, and immediately centrifuged. The cells were washed twice with ice-cold phosphate-buffered saline (PBS)/O. 1 % bovine serum albumin (BSA) containing 0.1% sodium azide and incubated with the murine MoAb 3936 at a concentration of 2 pg/mL for 30 minutes at 4°C. After extensive washing, cells were incubated for 30 minutes at 4°C with the fluorescein DTAF-conjugated anti-IgG (dilution, 11200). After extensive washing, the cells were fixed overnight with 2% paraformaldehyde and analyzed by flow cytometry as described above. Nonspecific binding was assessed by replacing MoAb 3936 with an irrelevant mouse IgGI.
Preparation of RNA, cRNA probes, and Northern blot analysis. Total RNA of U937 cells was extracted according to the method of Chomczynski et Total RNA (15 pg) was fractionated by electrophoresis on 1% gel agarose containing 20% formaldehyde. RNA was transferred under vacuum to a positively charged nylon membrane. The antisense cRNA probe of PAL1 was transcribed in vitro from linearized recombinant plasmid (containing the 436-bp fragment from nucleotide 1045 to 1481 of human PAI-l) using digoxigenin-l l-uridine triphosphate and SP6 RNA polymerase (Boehringer Mannheim) according to the protocol described by Melton et al. 49 The digoxigenin-labeled human P-actin antisense cRNA probe was from Boehringer Mannheim Biochemical. Hybridization was performed with the digoxigenin-labeled antisense cRNA probes of human PAL1 and p-actin for 16 hours at 68°C under gentle stirring, as previously described?' Detection of the RNA-cRNA hybrid was performed using a chemiluminescent detection kit as described by the manufacturer (Boehringer Mannheim Biochemical, no. 1363514). Briefly, after hybridization, blots were incubated with an antidigoxigenin MoAb conjugated to alkaline phosphatase. The reaction was initiated by addition of alkaline phosphatase substrate, and the membrane was exposed to an autoradiography film for a period of time ranging between 15 and 30 minutes.
RESULTS
Effect of A231 87, TG, TNF, and IL-l on cytosolic calcium mobilization. A23187 and TG are well known to induce in various types of cells, each via a different way, an increase in cytosolic calcium concentration. We analyzed by flow cytometry the characteristics of cytosolic calcium mobilization induced by these molecules. Cells were stimulated with A23187 or TG at the indicated concentrations. Fluorescence was read 10 seconds and 60 seconds after addition of A23 187 and TG, respectively, which was determined to be the optimal time for each. With A23187, increasing the dose up to 1 pmol/L lead to a significant increase in intensity of fluorescence. Above 1 pmol/L, no further increase in fluorescence was observed (Fig 1A) . TG also induced a dosedependent increase in fluorescence, much less marked in intensity but occurring at a concentration 10 times lower than with A23187 (Fig 1B) . The dose response appeared narrower with TG than with A23187 and reached a plateau at approximately 0.5 pmoVL and 0.05 pmol/L with A23 187 and TG, respectively. To further confirm the calcium-mobilizing effect of the agents, we analyzed the calcium mobilization in cells preincubated in a calcium-free medium for 2 hours and subsequently stimulated. The fluorescence was read 10 and 60 seconds after the stimulation with A23187 and TG, respectively. Compared with cells in a normal calcium concentration, we observed a drastic diminution of the fluorescence signal when cells were incubated in the calcium-free medium and stimulated with the agents (Fig l ,  insets) . The diminution of the signal attained 93% and 80% for A23187 and TG, respectively. Replacing calcium in the culture medium at a final concentration of 2 mmoVL for I5
minutes allowed detection of a fluorescence signal when cells were stimulated with A23 187 or TG, although for both the signals were slightly less intense than under normal conditions of stimulation (Fig 1, insets) . We then investigated the calcium mobilization in cells stimulated by TNF with or without the agents. Cells were treated for 2 hours with TNF, loaded with the dye, and then stimulated with either A23187 or TG, and the fluorescence was read 10 seconds and 60 seconds after the stimulation, respectively. Results were compared with cells stimulated with calcium-mobilizing by TNF, we analyzed the response at a single-cell level using digital imaging microscopy. Results were consistent with flow cytometry observations, as about 40% of the cells responded to TNF within the first 10 minutes and displayed a heterogenous response, as shown in Fig 3. In our experimental protocol of stimulation designed to study the regulation of PAL 1 synthesis, cells were stimulated for 30 minutes, the agent was removed, and incubation was continued in 1% FCS (see below). Therefore, we investigated by flow cytometry how long the increase in the level of cytosolic calcium persisted in cells after removal of the agent. As shown in Table 1 , A23 187-stimulated cells did not sustain an elevated cytosolic calcium level, as 30 minutes after the removal of A23187, the fluorescence nearly returned to the level of control cells. In contrast, in TG-stimulated cells, the fluorescence remained at a constant level comparable with that read at the initial measurement (compare with Fig 1) . This indicates that the effect of TG on intracellular calcium, in contrast with that of A23 187, persisted after its removal from the medium.
We investigated if the weak calcium mobilization induced by cytokines was mediated by inositol phosphate-3 (IP3) release. After labeling the cells with rny~[~H]inositol, they were stimulated with either TNF (100 UlmL) or IL-I (10 U/ mL) for 0,2,5, 10, and 15 minutes. Any significant increase in IPS above the control level was detected in these conditions (data not shown).
Effects of A23187, TG, and cytokines on PAI-I accumulation in the culture medium. Cells in 1% FCS medium were stimulated for 30 minutes with increasing doses of A23187 or TG. As shown in Fig 4, both agents induced a dosedependent effect on PAI-1 accumulation, which was more pronounced with TG than with A23187. The response was linearly related to a dose up to 1 pmol/L and 0.1 p m o K for A23187 and TG, respectively, and then declined for A23187 and plateaued for TG. Evaluation of cell viability, performed by the trypan blue dye exclusion test, did not reveal significantly higher cell injury, except for at the highest dose of A23187. This is confirmed by the measurement of LDH in culture medium, which showed for this dose an increased release in the culture medium (X4) that represents about 30% of the total intracellular LDH that can be released (data not shown). Therefore, the decrease in PAI-1 accumulation at 2 pmoVL A23 187 could be related to a cytotoxic effect of the molecule at this concentration. Combining the results of the dose-dependent calcium mobilization (Fig 1) and PAI-1 accumulation (Fig 4) enabled us to set the experimental concentrations of A23187 and TG in all subsequent studies at 1 pmoYL and 0.1 pmoVL, respectively. The doses of 100 U/mL of TNF and 10 U/mL of IL-1 optimally induced over control cells about 22 times and five times more secreted PAL1 Ag, respectively. TNF at 100 U/mL was, thus, selected in the subsequent studies. When TNF-stimulated In the experiments with TNF alone, TNF was added as a single dose 1100 UlmL) and left for 2.5 hours. Cells were then washed, and TNF (100 U/mL) was added again as a single dose. In the experiments associating TNF and agent, the agent was added 2 hours after initial addition of TNF and left for 30 minutes, and the experiment continued as indicated above. Media were recovered 18 hours after agent addition (ie, 20 hours after initial TNF addition). There was no significant difference in the accumulation of PAL1 whether the agent was added at the same time as TNF (not shown) or 2 hours after. cells were incubated for 30 minutes with A23187 ( I pmol/ L) or TG (0. I pmol/L), the accumulation of PAI-1 was more than additive of the two separately (Fig S) . In all the situations, the protein synthesis inhibitor cycloheximide drastically abolished the increase in PAL I accumulation, indicating that neither agents nor TNF induced the release of a preformed pool of PAI-I. To confirm the role of calcium in PAI-I release, cells were preincubated in a calcium-free medium 2 hours before the stimulation and throughout the experiment. Results were compared with those treated under the same conditions at normal calcium concentration. Results are listed in Table 2 . Incubation in the calcium-free medium almost totally prevented the A23187-or TG-induced increase in PAI-l. Incubation in a calcium-free medium was not cytotoxic as judged by LDH release. However, those stimulated with A23 187 in the calcium-free medium released slightly more LDH (+40%). Deprivation of extracellular calcium reduced by about 47% the TNF-induced increase in the release of PAI-I. Insets in Fig I show that even after a preincubation with EGTA, calcium is still mobilizable by agents, although weakly. This minor pool may account for the remaining 53% of PAI-I in EGTA-treated cells stimulated with TNF. Therefore, we used the intracellular calcium chelator BAPTA-AM at a concentration of 1 pmol/L, which was shown not to be cytotoxic at this concentration. Cells were preincubated with EGTA for 2 hours and then incubated with BAPTA-AM for 30 minutes. We first checked by flow cytometry that the stimulation of these calciumchelated cells by A23 187 did not induce any greater increase in fluorescence, attesting for the complete absence of mobi- lizable calcium. These calcium-chelated cells were stimulated by TNF for 18 hours. Table 2 shows that TNF-induced PAI-I release from calcium-chelated cells was similar to EGTA-treated cells. This indicates that the remaining intracellular calcium after EGTA preincubation is not responsible for the TNF-induced PAI-I secretion from EGTA-treated cells. Curiously, TNF-treated cells incubated with BAPTA-AM released about twice more PAI-I than cells treated with TNF alone. In unstimulated control cells, deprivation of extracellular calcium reduced the basal accumulation of PAI-1 by 70%, whereas BAPTA-AM increased the basal accumulation by about a factor of 3.
Effect of A23187, TG, and TNF on uPA accumulation in culture medium and uPAR membrane expression. The same experimental conditions were applied to analyze the synthesis of uPA and its receptor (Table 3) . Calcium-mobilizing agents alone did not induce significant alteration in uPA Ag accumulation in the culture medium, whereas TNF produced about a threefold increase over the control cells. Association of TNF with either A23187 or TG tended to decrease the TNF-induced increase in uPA Ag. Flow cytometry analysis of uPAR showed that its membrane surface expression was not significantly altered by TNF at 5, 10, and 18 hours.
However, calcium-mobilizing agents either alone or in association with TNF tended to increase the surface expression of uPAR mainly at 18 hours when com-A PElRElTl ET AL pared with unstimulated cells. Although statistically not significant, the effects appeared slightly more marked at 10 hours and 18 hours with A23 187 ( + 4 1 8 and +65%, respectively) than with TG ( + 2 1 8 at 18 hours). As a positive control of uPAR surface expression, U937 cells were treated twice with 5 pmol/L of phorbol myristate acetate (PMA) at 24-hour intervals. Approximately a 10-fold increased surface expression of uPAR was detected in PMA-treated cells over control cells (data not shown).
Effect ?f A23I87, TG, and TNF on PAI-I mRNA level. To see if the augmentation of PAI-I release in medium induced by calcium-mobilizing agents was linked to its mRNA expression, we analyzed by Northern blot the PAI-1 mRNA expression at different times after stimulation with calcium-mobilizing agents. As shown in Fig 6, PAI-I mRNA (3.2 and 2.3 kb transcripts) expression was strongly induced 3 hours after the onset of agent stimulation and then declined at 5 hours both for A23 187 and TG. At I8 hours, expression almost disappeared with A23187, whereas the signal remained quite stable with TG. TNF alone or in association with the agents was then studied. TNF alone ( 1 0 0 U/mL; Fig 7A and B) induced a slight PAI-I mRNA expression 3 hours after the onset of stimulation. The signal remained the same at 5 hours and disappeared at 7 hours. When calciummobilizing agents were added in association with TNF ( Fig  7A and B) , the profile of the time-dependent PAI-I mRNA expression was comparable with that observed when the agents were added alone (compare with Fig 6) ; ie, with TG, the expression of PAI-I mRNA remained quite constant from 7 hours up to 18 hours, whereas with A23187, it declined. To see the effect of the association of TNF with calcium-mobilizing agents on PAI-I mRNA, we compared its expression at a fixed time (3 hours after the addition of the agent, ie, 5 hours after initial addition of TNF) under different conditions: control, 1% FCS; TNF (100 U/mL); For personal use only. on October 3, 2017. by guest www.bloodjournal.org From expression, which was even higher for the 3.2-kb form (Fig  8) . PAI-I mRNA expression of cycloheximide-treated cells was identical to that of control cells (data not shown). The effect of calcium-free medium on PAI-I mRNA expression in cells stimulated with A23 187 or TG was investigated. Interestingly, the A23187-or TG-induced increase in mRNA normally observed 3 hours after the beginning of stimulation in standard calcium concentration was now completely abolished by deprivation of extracellular calcium (Fig 8) .
DISCUSSION
We investigated the role of calcium-mobilizing agents (ionophore A23187 and TG) alone or in association with TNF in the regulation of PAI-I synthesis and extended the study to include uPA and uPAR. Both calcium-mobilizing agents induced a drastic increase in PAI-I accumulation in the culture medium. Three arguments are in favor of a calciummediated effect. (1) The two structurally unrelated molecules dramatically stimulated PAI-I accumulation, thus ruling out a possible side effect unrelated to calcium. (2) A comparable shape of the dose-dependence curves of PAI-I release and calcium mobilization was observed with either A23187 or TG. (3) The complete chelation of extracellular calcium drastically prevented the agent-induced increase in PAI-I release. This is reflected by flow cytometry analysis, revealing that in cells cultured for 2 hours in a calcium-free medium, calcium mobilization was strongly reduced. Therefore, depletion of the extracellular calcium 2 hours before stimulation practically emptied the agent-sensitive intracellular stores by a progressive efflux of calcium from these stores to the outside of the cell. This is in agreement with studies clearly showing that a calcium-free medium resulted in a significant loss of calcium from intracellular How- PEIRElTI ET AL ever, chelating extracellular calcium did not irreversibly affect the ability of cells to maintain calcium homeostasis. The upregulation of PAL 1 accumulation induced by elevated levels of cytosolic calcium is not due to the secretion of a preformed pool of PAI-1. First, cycloheximide suppressed the agent-induced secretion of PAI-l. Secondly, the PAL1 mRNA expression was drastically increased after stimulation by either A23 187 or TG. The effect of TG on PAI-1 mRNA expression persisted for a longer time than that of A23187. This may be the result of the irreversible inactivation of the Ca2'-ATPase pump by TG?' which prolonged the increase in cytosolic calcium for a longer period than with A23187. Indeed, we showed that the calcium-mobilizing effect of TG remained at its initial value 90 minutes after the agent had been eliminated, whereas it disappeared rapidly with A23187. Whether this higher level of mRNA is due to an enhanced transcription rate of the gene andor a higher stabilization of PAL1 mRNA has not been investigated here. Because the basal level of PAI-1 mRNA in quiescent cells is undetectable, it is likely that the markedly elevated level of PAI-l mRNA after stimulation mainly results from an enhanced transcription process. However, a stabilizing effect on PAI-l mRNA cannot be ruled out, as it has been demonstrated with A23187 on IL-3 ~IRNA.'~ A calcium-free medium totally prevented the increase in mRNA expression after stimulation by the calcium-mobilizing agent, which again reinforces the role of calcium as an important intracellular messenger involved in the regulation of PAI-I gene expression. The calcium effect does not require a de novo protein synthesis, because treatment of cells with cycloheximide did not suppress A23187-and TG-induced PAI-I mRNA expression. A slight overincrease in the 3.2-kb transcript expression was observed, a phenomenon explained by a stabilizing effect of cycloheximide on this mRNA.s4.55
The interaction of calcium-mobilizing agents with TNF is of interest. TNF upregulates PAL1 production and mRNA expression in U937 cells, which has already been reported in various tissues" and other types of cells.57 The role of calcium mobilization in signal transduction by TNF is still controver~ial.*~*~~ Some of the discrepancies reported can be explained by the calcium-buffering capacities of the fluorescent probe used" and/or by the different sensitivity of cells to TNF. Using Fluo3, we found in U937 cells that TNF alone weakly mobilized calcium. In other types of cells, the use of F~r a 2 '~,~ did not allow detection of any significant calcium increase after stimulation by TNF even at very high doses:' whereas in human neutrophils stimulated with TNF at 1,000 U/mL, calcium oscillations were observed with Flu03 in some of the responsive cells. 62 The modest increase we observed with TNF did not appear to be the result of a calcium release from IP3-sensitive stores, as we could not measure any significant IP production. This is consistent with previous results6' and with our digital imaging microscopy observations that showed a heterogeneous slow calcium increase in about 40% of cells. IP3 is known to be rapidly produced and to induce within minutes a transient significant increase in calcium. However, the possibility that a secondary, very late, and low sustained increase in IP3 occurs cannot be ruled out.@ It is evident from our results that calcium is not indispensable but does contribute to the TNF-induced pathway of PAI-1 synthesis. In support of a contributive role, calcium-mobilizing agents and EGTA have an opposite effect on PAI-1 Ag production triggered by TNF. On the other hand, calcium is not indispensable for TNF action. because in experiments in which both extracellular and intracellular calcium have been buffered, TNF still induced about 60% of PAI-1 release. The individual opposite effects of BAPTA-AM and EGTA on PAL1 synthesis in TNF-stimulated cells deserve some comments. By preventing the refilling of intracellular stores, BAPTA-AM may secondarily induce a calcium influx, in a comparable manner to the effect of TG.6'-hs In the presence of TNF and EGTA, BAPTA-AM did not further lower the reduced PAI-1 response provoked by EGTA, suggesting that chelation of extracellular calcium was a determinant to reduce the TNF action on PAL I synthesis. Collectively, these data suggest that calcium influx plays an important role in the upregulation of PAL1 synthesis triggered by TNF. Recently, it was found in adherent human fibroblasts that extracellular calcium predominates in IL-Istimulated calcium Thus, we can hypothesize that a calcium influx induced by either TNF or calcium-mobilizing agents primes at a certain step a common pathway that regulates PAI-1 expression. The tyrosine kinase pathway is a possible candidate. Recently, it has been shown in human endothelial cells that TNF-induced increase in PAI-1 gene transcription follows a genistein-sensitive pathway involving a tyrosine kinase phosphorylation ~t e p .~" Interestingly, in human lymphocytes, the influx of calcium controlled by the filling state of intracellular calcium pools is regulated by the tyrosine kinase activity." Also, TNF"," and calcium activate the MAP kinase pathway, and TNF potentiates calcium signals induced by brad~kinin.'~ The potentiating effect of agents on calcium mobilization and PAI-l synthesis in TNF-stimulated cells could not be observed at the level of PAL1 mRNA. The stability and export of mRNA and the translation efficiency are intermediate control mechanisms that may be significantly altered by the different treatments, thus preventing establishment of a rigorous relationship between mRNA expression and its corresponding protein released in the culture medium. Therefore, whether this effect acts at a transcriptional, posttranscriptional, or translational level cannot be determined on the basis of the present data.
The triad PAI-l/uPA/uPAR is believed to regulate pericellular proteolysis, which conditions cell rnigrati~n.~~'' We, therefore, investigated uPA and uPAR expression. We found that uPAR membrane expression was not significantly altered by TNF and was weakly altered by calcium-mobilizing agents 18 hours after the stimulation. However, uPAR surface expression may be transient. First, uPAR can be internalized by the low-density lipoprotein receptor-related protein (LRP) together with uPA/PAI-I and recycled back to the membrane.72 Second, uPAR can be released from the membrane into the medium.'' Thus, we investigated the possibility that we missed a more marked transient uPAR expression before 18 hours. This does not appear to be the case, because no significantly higher surface expression could be observed over control cells at 5 hours and 10 hours after the Stimulation. Thus, it is reasonable to assume that within the For personal use only. on October 3, 2017. by guest www.bloodjournal.org From duration of the experiment, only calcium-mobilizing agents tended to induce a weak uPAR surface expression. Under our experimental conditions (ie, 18 hours after the stimulation), A23187 or TG alone did not increase uPA accumulation in the medium, which is in accordance with previous data.35 TNF increased uPA release as already although to a much lesser extent than PAI-1. Interestingly, calciummobilizing agents did not potentiate TNF-induced uPA release, indicating that the upregulation exerted by the calcium agents either themselves or in interaction with TNF appears specific for PAI-1 within the proteins regulating the surface proteolysis. It may be hypothesized that in monocytes the calcium-mediated signal that specifically upregulates PAI-1 production shifts the pericellular proteolytic potential toward hypoproteolysis or hypofibrinolysis.
In conclusion, our results demonstrate the role of calcium as being an intracellular messenger able to upregulate the expression of PAI-l in U937 cells and also to interact with TNF by potentiating its effect. This process may be of prime importance in the migration and recruitment of activated monocytes/macrophages during atherosclerosis, as recently sugge~ted,'~.'~ or in the focal accumulation of PAI-1 in a lesion contributing to fibrin deposition.
